胃轉流術對代謝綜合征改善作用的研究進展_《中國普外基礎與臨床雜志》

作者：

戴露倢 ¹ , 王瑜 ² , 王烈 ² , 黃盛 ²

1.安徽醫科大學第一臨床醫學院（安徽合肥 230032）;;
2.南京軍區福州總醫院普通外科（福建福州 350025）;

關鍵詞：

代謝綜合征胃轉流胰島素抵抗糖尿病

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的探討胃轉流術（GBP）對代謝綜合征（MS）的影響及其作用機理。方法通過復習文獻，回顧分析GBP對糖脂代謝和血壓變化的影響。結果GBP術后數天內，70%以上MS患者血糖、血脂達正常水平，血壓控制有明顯改善，而體重減輕遲于血糖、血脂變化。飲食、胃腸激素、脂肪細胞因子、脂肪分布等因素的改變參與GBP對MS的改善作用。結論GBP似乎對控制MS有原發的、獨立的影響，而非繼發于對肥胖癥的治療。

引用本文： 戴露倢,王瑜,王烈,黃盛. 胃轉流術對代謝綜合征改善作用的研究進展. 中國普外基礎與臨床雜志, 2011, 18(2): 216-219. doi: 復制

1.	Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic RouxenY gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women [J]. Obes Surg, 2009, 19(5): 577582.
2.	Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition [J]. Lancet, 2005, 366(9491): 10591062.
3.	Sjstrm L, Narbro K, Sjstrm CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects [J]. N Engl J Med, 2007, 357(8): 741752.
4.	Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13 871 morbidly obese patients from a national registry [J]. Ann Surg, 2007, 246(6): 10021009.
5.	Yarbrough DE, Leath RR, Leeth TD, et al. Longterm improvement of gastrointestinal complaints following weight loss in patients undergoing laparoscopic RouxenY gastric bypass (LRYGBP) [J]. ASMBS, 2006, 2(3): 296297.
6.	Bose M, Oliván B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? [J]. Obes Surg, 2009, 19(2): 217229.
7.	Puzziferri N, AustrheimSmith IT, Wolfe BM, et al. Threeyear followup of a prospective randomized trial comparing laparoscopic versus open gastric bypass [J]. Ann Surg, 2006, 243(2): 181188.
8.	Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10y followup [J]. Am J Clin Nutr, 1992, 55(2 Suppl): 582S585S.
9.	Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial [J]. JAMA, 2008, 299(3): 316323.
10.	Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis [J]. Am J Med, 2009, 122(3): 248256.
11.	Rossi M, R Barretto Ferreira da Silva R, Chaves Alcntara G Jr, et al. Remission of metabolic syndrome: a study of 140 patients six months after RouxenY gastric bypass [J]. Obes Surg, 2008, 18(5): 601606.
12.	Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following RouxenY gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity [J]. Obes Surg, 2007, 17(2): 176184.
13.	Zlabek JA, Grimm MS, Larson CJ, et al. The effect of laparosscopic gastric bypss surgery on dyslipidemia in severely obese patients [J]. Surg Obes Relat Dis, 2005, 1(6): 537542.
14.	Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and metaanalysis [J]. JAMA, 2004, 292(14): 17241737.
15.	Ali MR, Fuller WD, Rasmussen J. Detailed description of early response of metabolic syndrome after laparoscopic RouxenY gastric bypass [J]. Surg Obes Relat Dis, 2009, 5(3): 346351.
16.	鄧治洲, 王烈, 林憶陽, 等. 胃轉流術對非肥胖型2型糖尿病的療效觀察及其對胰高血糖樣肽1的影響 [J]. 中國普外基礎與臨床雜志, 2009, 244(9): 466469.
17.	Scopinaro N, Papadia F, Marinari G, et al. Longterm control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2 [J]. Obes Surg, 2007, 17(2): 185192.
18.	Couzin J. Bypassing medicine to treat diabetes [J]. Science, 2008, 320(5875): 438440.
19.	DePaula AL, MacedoAL, Schraibman V, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 2034 [J]. Surg Endosc, 2008, 23(8): 17241732.
20.	Ballantyne GH, Farkas D, Laker S, et al. Shortterm changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic RouxenY gastric bypass [J]. Obes Surg, 2006, 16(9): 11891197.
21.	Haider DG, Schindler K, Schaller G, et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding [J]. J Clin Endocrinol Metab, 2006, 91(4): 15781581.
22.	Koh KK, Quon MJ, Lee SJ, et al. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension [J]. Diabetes Care, 2007, 30(6): 16051607.
23.	Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men [J]. JAMA, 2004, 291(14): 17301737.
24.	Choi KM, Lee J, Lee KW, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans [J]. Clin Endocrinol (Oxf), 2004, 61(1): 7580.
25.	Choi EY, Park EH, Cheong YS, et al. Association of Creactive protein with the metabolic risk factors among young and middleaged Korean [J]. Metabolism, 2006, 55(3): 415421.
26.	GómezAmbrosi J, Pastor C, Salvador J, et al. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass [J]. Obes Surg, 2007, 17(5): 585591.
27.	Kotronen A, SepplLindroos A, Bergholm R, et al. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome [J]. Diabetologia, 2008, 5(1): 130138.
28.	Stearns AT, Balakrishnan A, Tavakkolizadeh A. Impact of RouxenY gastric bypass surgery on rat intestinal glucose transport [J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297（5）: G950G957.
29.	Rao MN, Mulligan K, Tai V, et al. Effects of insulinlike growth factor (IGF)I/IGFbinding protein3 treatment on glucose metabolism and fat distribution in human immunodeficiency virusinfected patients with abdominal obesity and insulin resistance [J]. J Clin Endocrinol Metab, 2010, 95(9): 43614366.
30.	Wang X, Zhang S, Chen Y, et al. APM1 gene variants11377C/G and 4545G/C are associated respectively with obesity and with nonobesity in Chinese type 2 diabetes [J]. Diabetes Res Clin Pract, 2009, 84(3): 205210.
31.	Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations [J]. Diab Vasc Dis Res, 2007, 4(1): 1319.
32.	Swarbrick MM, Stanhope KL, AustrheimSmith IT, et al. Longitudinal changes in pancreatic and adipocyte hormone following RouxenY gastric bypass surgery [J]. Diabetolog, 2008, 51(10): 19011911.
33.	周龍翔, 汪昱, 楊喆, 等. 胃癌術后不同殘胃患者胃腸激素及機體組成變化 [J]. 中國普外基礎與臨床雜志, 2009, 16(4): 290295.

1. Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic RouxenY gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women [J]. Obes Surg, 2009, 19(5): 577582.
2. Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition [J]. Lancet, 2005, 366(9491): 10591062.
3. Sjstrm L, Narbro K, Sjstrm CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects [J]. N Engl J Med, 2007, 357(8): 741752.
4. Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13 871 morbidly obese patients from a national registry [J]. Ann Surg, 2007, 246(6): 10021009.
5. Yarbrough DE, Leath RR, Leeth TD, et al. Longterm improvement of gastrointestinal complaints following weight loss in patients undergoing laparoscopic RouxenY gastric bypass (LRYGBP) [J]. ASMBS, 2006, 2(3): 296297.
6. Bose M, Oliván B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? [J]. Obes Surg, 2009, 19(2): 217229.
7. Puzziferri N, AustrheimSmith IT, Wolfe BM, et al. Threeyear followup of a prospective randomized trial comparing laparoscopic versus open gastric bypass [J]. Ann Surg, 2006, 243(2): 181188.
8. Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10y followup [J]. Am J Clin Nutr, 1992, 55(2 Suppl): 582S585S.
9. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial [J]. JAMA, 2008, 299(3): 316323.
10. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis [J]. Am J Med, 2009, 122(3): 248256.
11. Rossi M, R Barretto Ferreira da Silva R, Chaves Alcntara G Jr, et al. Remission of metabolic syndrome: a study of 140 patients six months after RouxenY gastric bypass [J]. Obes Surg, 2008, 18(5): 601606.
12. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following RouxenY gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity [J]. Obes Surg, 2007, 17(2): 176184.
13. Zlabek JA, Grimm MS, Larson CJ, et al. The effect of laparosscopic gastric bypss surgery on dyslipidemia in severely obese patients [J]. Surg Obes Relat Dis, 2005, 1(6): 537542.
14. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and metaanalysis [J]. JAMA, 2004, 292(14): 17241737.
15. Ali MR, Fuller WD, Rasmussen J. Detailed description of early response of metabolic syndrome after laparoscopic RouxenY gastric bypass [J]. Surg Obes Relat Dis, 2009, 5(3): 346351.
16. 鄧治洲, 王烈, 林憶陽, 等. 胃轉流術對非肥胖型2型糖尿病的療效觀察及其對胰高血糖樣肽1的影響 [J]. 中國普外基礎與臨床雜志, 2009, 244(9): 466469.
17. Scopinaro N, Papadia F, Marinari G, et al. Longterm control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2 [J]. Obes Surg, 2007, 17(2): 185192.
18. Couzin J. Bypassing medicine to treat diabetes [J]. Science, 2008, 320(5875): 438440.
19. DePaula AL, MacedoAL, Schraibman V, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 2034 [J]. Surg Endosc, 2008, 23(8): 17241732.
20. Ballantyne GH, Farkas D, Laker S, et al. Shortterm changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic RouxenY gastric bypass [J]. Obes Surg, 2006, 16(9): 11891197.
21. Haider DG, Schindler K, Schaller G, et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding [J]. J Clin Endocrinol Metab, 2006, 91(4): 15781581.
22. Koh KK, Quon MJ, Lee SJ, et al. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension [J]. Diabetes Care, 2007, 30(6): 16051607.
23. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men [J]. JAMA, 2004, 291(14): 17301737.
24. Choi KM, Lee J, Lee KW, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans [J]. Clin Endocrinol (Oxf), 2004, 61(1): 7580.
25. Choi EY, Park EH, Cheong YS, et al. Association of Creactive protein with the metabolic risk factors among young and middleaged Korean [J]. Metabolism, 2006, 55(3): 415421.
26. GómezAmbrosi J, Pastor C, Salvador J, et al. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass [J]. Obes Surg, 2007, 17(5): 585591.
27. Kotronen A, SepplLindroos A, Bergholm R, et al. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome [J]. Diabetologia, 2008, 5(1): 130138.
28. Stearns AT, Balakrishnan A, Tavakkolizadeh A. Impact of RouxenY gastric bypass surgery on rat intestinal glucose transport [J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297（5）: G950G957.
29. Rao MN, Mulligan K, Tai V, et al. Effects of insulinlike growth factor (IGF)I/IGFbinding protein3 treatment on glucose metabolism and fat distribution in human immunodeficiency virusinfected patients with abdominal obesity and insulin resistance [J]. J Clin Endocrinol Metab, 2010, 95(9): 43614366.
30. Wang X, Zhang S, Chen Y, et al. APM1 gene variants11377C/G and 4545G/C are associated respectively with obesity and with nonobesity in Chinese type 2 diabetes [J]. Diabetes Res Clin Pract, 2009, 84(3): 205210.
31. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations [J]. Diab Vasc Dis Res, 2007, 4(1): 1319.
32. Swarbrick MM, Stanhope KL, AustrheimSmith IT, et al. Longitudinal changes in pancreatic and adipocyte hormone following RouxenY gastric bypass surgery [J]. Diabetolog, 2008, 51(10): 19011911.
33. 周龍翔, 汪昱, 楊喆, 等. 胃癌術后不同殘胃患者胃腸激素及機體組成變化 [J]. 中國普外基礎與臨床雜志, 2009, 16(4): 290295.

《中國普外基礎與臨床雜志》

胃轉流術對代謝綜合征改善作用的研究進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

胃轉流術對代謝綜合征改善作用的研究進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料